ASX · AVR.AX
Anteris Technologies Ltd
A$8.55A$0.00 (0.0%)
Anteris Technologies Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.92% below the high.
Loading market information…
OTC · COPHF · USD
Stock price, earnings
Quote as of Nov 7, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Creso Pharma Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Creso Pharma Limited is a global pharmaceutical company focused on the development, registration, and commercialization of advanced cannabis and hemp-based solutions. These therapeutic products and nutraceuticals are designed for both human and animal health applications, with market presence spanning Europe, the Middle East, North America, and the Asia Pacific region. Beyond innovative product creation, the company also manages the cultivation, processing, and distribution of cannabis products, extending its reach to the retail sector. Its diverse portfolio includes specialized offerings such as anibidiol, a complementary nutritional supplement for companion animals. For human wellness, they provide cannaQIX, a nutraceutical blend of hemp oil extract, vitamins, and zinc, formulated to alleviate stress and bolster psychological and neurological functions. The company also manufactures topical and dermatological products, including cannaDOL, a CBD-infused gel combining cooling and warming essential oils. Established in 2015, Creso Pharma Limited maintains its headquarters in Nedlands, Australia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$8.55A$0.00 (0.0%)
Anteris Technologies Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.92% below the high.
£202.78£0.00 (0.0%)
Diaceutics PLC’s quoted price sits in the upper half of its reported 52-week range, 3.1% below the high.
$0.43$0.00 (0.0%)
Cell MedX Corp.: Healthcare · Medical - Devices.
$37.00$0.00 (0.0%)
Leafly Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.78% below the high.
HK$0.90HK$0.00 (0.0%)
Tian An Medicare Limited’s quoted price sits in the lower half of its reported 52-week range, 34.19% below the high.
$1.72$0.00 (0.0%)
BioHarvest Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.4% below the high.
